| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
mal, T cell differentiation protein | 0.570 | 0.577 | 0.83 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2015 | 2015 | ||||||||
|
NADH:ubiquinone oxidoreductase subunit B2 | 0.743 | 0.538 | 1.1E-05 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2016 | 2016 | ||||||||
|
nicotinamide N-methyltransferase | 0.559 | 0.654 | 5.3E-08 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2014 | 2014 | ||||||||
|
prolactin induced protein | 0.556 | 0.808 | 6.8E-04 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2019 | 2019 | ||||||||
|
interleukin 17D | 0.464 | 0.808 | 0.20 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2012 | 2012 | ||||||||
|
DNA polymerase gamma, catalytic subunit | 0.457 | 0.846 | 2.1E-09 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2015 | 2015 | ||||||||
|
interleukin 17 receptor D | 0.617 | 0.654 | 1.1E-06 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2019 | 2019 | ||||||||
|
CDK5 regulatory subunit associated protein 1 like 1 | 0.617 | 0.615 | 1.6E-02 |
|
disease | 0.010 | None | < 0.001 | 1 | 1 | 2012 | 2012 | ||||||||
|
terminal nucleotidyltransferase 5A | 0.695 | 0.577 | 0.92 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2006 | 2006 | ||||||||
|
A-kinase interacting protein 1 | 0.705 | 0.308 | 1.1E-05 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2018 | 2018 | ||||||||
|
prostaglandin D2 receptor | 0.650 | 0.615 | 3.6E-06 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2015 | 2015 | ||||||||
|
RAS p21 protein activator 2 | 0.579 | 0.769 | 7.4E-31 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2019 | 2019 | ||||||||
|
parvin gamma | 0.805 | 0.115 | 1.4E-05 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2003 | 2003 | ||||||||
|
signal sequence receptor subunit 1 | 0.711 | 0.269 | 0.27 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2008 | 2008 | ||||||||
|
thrombospondin 4 | 0.644 | 0.654 | 1.5E-18 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2010 | 2010 | ||||||||
|
transmembrane phosphatase with tensin homology | 0.821 | 0.308 | 5.6E-24 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2015 | 2015 | ||||||||
|
defensin alpha 1B | 0.674 | 0.692 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2007 | 2007 | |||||||||
|
matrix metallopeptidase 28 | 0.653 | 0.462 | 6.1E-05 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2017 | 2017 | ||||||||
|
suppression of tumorigenicity 7 | 0.743 | 0.192 | 1.00 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2004 | 2004 | ||||||||
|
prostate stem cell antigen | 0.555 | 0.615 | 0.17 |
|
disease | 0.010 | None | < 0.001 | 1 | 2 | 2015 | 2015 | ||||||||
|
cell wall biogenesis 43 C-terminal homolog | 0.931 | 0.115 | 7.3E-22 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2014 | 2014 | ||||||||
|
neuropilin and tolloid like 2 | 0.780 | 0.192 | 6.3E-02 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2017 | 2017 | ||||||||
|
caspase 10 | 0.528 | 0.692 | 4.6E-12 |
|
disease | 0.010 | None | < 0.001 | 1 | 1 | 2013 | 2013 | ||||||||
|
cellular communication network factor 4 | 0.554 | 0.692 | 6.4E-07 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2010 | 2010 | ||||||||
|
zinc finger and BTB domain containing 24 | 0.659 | 0.654 | 2.1E-04 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2008 | 2008 |